The Impact of Creatinine Clearance Rate, Daily Urinary Albumin, and Their Joint Effect on Predicting Death in Diabetic Inpatients after Discharge

Medicine (United States)

Volumn 95, Issue 6, 2016, Pages

  Lee, I Te ^a,b   Sheu, Wayne H H ^a,b   Lin, Shih Yi ^a,c  

^a TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^b CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^c NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; CREATININE;

ADULT; ARTICLE; BODY MASS; COHORT ANALYSIS; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; DIABETIC NEPHROPATHY; DIABETIC PATIENT; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HOSPITAL DISCHARGE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MORTALITY RATE; OBSERVATIONAL STUDY; PRIORITY JOURNAL; RENAL CLEARANCE; TAIWAN; URINE VOLUME; ALBUMINURIA; MIDDLE AGED; MORTALITY; PROGNOSIS; URINE;

ALBUMINURIA; COHORT STUDIES; CREATININE; DIABETIC NEPHROPATHIES; FEMALE; HUMANS; MALE; MIDDLE AGED; PATIENT DISCHARGE; PROGNOSIS;

EID: 84958280191     PISSN: 00257974     EISSN: 15365964     Source Type: Journal    
DOI: 10.1097/MD.0000000000002804     Document Type: Article

References (35)

1. Ayodele OE, Alebiosu CO. Burden of chronic kidney disease: An international perspective. Adv Chronic Kidney Dis. 2010;17:215-224.
2. Meguid El Nahas A, Bello AK. Chronic kidney disease: The global challenge. Lancet. 2005;365:331-340.
3. Hwang SJ, Tsai JC, Chen HC. Epidemiology, impact and preventive care of chronic kidney disease in Taiwan. Nephrology (Carlton). 2010;15(suppl 2):3-9.
4. Collins AJ, Foley RN, Chavers B, et al. United States Renal Data System 2011 Annual Data Report: Atlas of chronic kidney disease & end-stage renal disease in the United States. Am J Kidney Dis. 2012;59:A7e1-420.
5. American Diabetes Association. Standards of medical care in diabetes: 2014. Diabetes Care. 2014;37(suppl 1):S14-S80.
6. Pugliese G, Solini A, Fondelli C, et al. Reproducibility of albuminuria in type 2 diabetic subjects. Findings from the renal insufficiency and Cardiovascular Events (RIACE) study. Nephrol Dial Transplant. 2011;26:3950-3954.
7. Rigalleau V, Beauvieux MC, Gonzalez C, et al. Estimation of renal function in patients with diabetes. Diabetes Metab. 2011;37:359-366.
8. Levey AS, Bosch JP, Lewis JB, et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med. 1999;130:461-470.
9. Inker LA, Astor BC, Fox CH, et al. KDOQI US commentary on the 2012 KDIGO clinical practice guideline for the evaluation and management of CKD. Am J Kidney Dis. 2014;63:713-735.
10. Carnevale V, Pastore L, Camaioni M, et al. Estimate of renal function in oldest old inpatients by MDRD study equation, Mayo Clinic equation and creatinine clearance. J Nephrol. 2010;23: 306-313.
11. Gall MA, Hougaard P, Borch-Johnsen K, et al. Risk factors for development of incipient and overt diabetic nephropathy in patients with non-insulin dependent diabetes mellitus: prospective, observational study. Br Med J. 1997;314:783-788.
12. Gall MA, Borch-Johnsen K, Hougaard P, et al. Albuminuria and poor glycemic control predict mortality in NIDDM. Diabetes. 1995;44:1303-1309.
13. So WY, Kong AP, Ma RC, et al. Glomerular filtration rate, cardiorenal end points, and all-cause mortality in type 2 diabetic patients. Diabetes Care. 2006;29:2046-2052.
14. Wada T, Haneda M, Furuichi K, et al. Clinical impact of albuminuria and glomerular filtration rate on renal and cardiovascular events, and all-cause mortality in Japanese patients with type 2 diabetes. Clin Exp Nephrol. 2014;18:613-620.
15. Ninomiya T, Perkovic V, de Galan BE, et al. Albuminuria and kidney function independently predict cardiovascular and renal outcomes in diabetes. J Am Soc Nephrol. 2009;20:1813-1821.
16. Lipska KJ, Ross JS, Wang Y, et al. National Trends in US Hospital Admissions for hyperglycemia and hypoglycemia among Medicare Beneficiaries, 1999 to 2011. J Am Med Assoc Intern Med. 2014;174:1116-1124.
17. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet. 1986;1: 307-310.
18. Hemmelgarn BR, Manns BJ, Lloyd A, et al. Relation between kidney function, proteinuria, and adverse outcomes. J Am Med Assoc. 2010;303:423-429.
19. Chronic Kidney Disease Prognosis ConsortiumMatsushita K, van der Velde M, et al. . Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: A collaborative meta-Analysis. Lancet. 2010;375:2073-2081.
20. Hillege HL, Fidler V, Diercks GF, et al. Urinary albumin excretion predicts cardiovascular and noncardiovascular mortality in general population. Circulation. 2002;106:1777-1782.
21. Fox CS, Matsushita K, Woodward M, et al. Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without diabetes: A meta-Analysis. Lancet. 2012;380:1662-1673.
22. Afkarian M, Sachs MC, Kestenbaum B, et al. Kidney disease and increased mortality risk in type 2 diabetes. J Am Soc Nephrol. 2013;24:302-308.
23. Toyama T, Furuichi K, Ninomiya T, et al. The impacts of albuminuria and low eGFR on the risk of cardiovascular death, all-cause mortality, and renal events in diabetic patients: metaanalysis. PLoS One. 2013;8:e71810.
24. Parving HH, Lewis JB, Ravid M, et al., investigators D. Prevalence and risk factors for microalbuminuria in a referred cohort of type II diabetic patients: A global perspective. Kidney Int. 2006;69: 2057-2063.
25. MacIsaac RJ, Tsalamandris C, Panagiotopoulos S, et al. Nonalbuminuric renal insufficiency in type 2 diabetes. Diabetes Care. 2004;27:195-200.
26. Ekinci EI, Jerums G, Skene A, et al. Renal structure in normoalbuminuric and albuminuric patients with type 2 diabetes and impaired renal function. Diabetes Care. 2013;36:3620-3626.
27. Fioretto P, Mauer M, Brocco E, et al. Patterns of renal injury in NIDDM patients with microalbuminuria. Diabetologia. 1996;39:1569-1576.
28. White SL, Polkinghorne KR, Atkins RC, et al. Comparison of the prevalence and mortality risk of CKD in Australia using the CKD Epidemiology Collaboration (CKD-EPI) and Modification of Diet in Renal Disease (MDRD) Study GFR estimating equations: The AusDiab (Australian Diabetes, Obesity and Lifestyle) Study. Am J Kidney Dis. 2010;55:660-670.
29. Costanzo P, Pellicori P, Cleland J, et al. 116 the obesity paradox in type II diabetes mellitus. Impact of body mass index on prognosis. Heart. 2014;100(suppl 3):A66.
30. Preston SH, Stokes A. Obesity paradox: conditioning on disease enhances biases in estimating the mortality risks of obesity. Epidemiology. 2014;25:454-461.
31. Deeb A, Hadj-Aissa A, Ducher M, et al. The best way to detect elevated albuminuria. Nephron Clin Pract. 2011;117:c333-c340.
32. Hwang SJ, Yang WC, Lin MY, et al., Taiwan Society of Nephrology. Impact of the clinical conditions at dialysis initiation on mortality in incident haemodialysis patients: A national cohort study in Taiwan. Nephrol Dial Transplant. 2010;25:2616-2624.
33. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002;39:S1-266.
34. Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150: 604-612.
35. Matsushita K, Mahmoodi BK, Woodward M, et al. Comparison of risk prediction using the CKD-EPI equation and the MDRD study equation for estimated glomerular filtration rate. J Am Med Asoc. 2012;307:1941-1951.